Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S
3 Headache and Neurological Pain Research Group, Department of Medicine, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
4 Neurophysiopathology Unit, DiBrain Department, Aldo Moro University, Bari, Italy.
5 Athens Naval Hospital, Athens, Greece.
6 Istanbul Faculty of Medicine, Department of Neurology, Istanbul University, Istanbul, Turkey.
7 Department of Neurology and Algology, NÖROM, Gazi University Ankara, Ankara, Turkey.
8 Department of Neurology, University Hospital Schleswig-Holstein, Lübeck, Germany.
9 Department of Neurology, Akershus University Hospital, Lørenskog, Norway.
10 NorHead, Norwegian Centre for Headache Research, Akershus University Hospital, Lørenskog, Norway.
11 Department of General Practice, HELSAM, University of Oslo, Oslo, Norway.
12 Department of Neurology and Stroke Unit, Konventhospital Barmherzige Brüder Linz, Linz, Austria.
13 Headache Medical Center Linz, Linz, Austria.
14 Grenoble Alpes University, Division of Neurology, CHU of Grenoble, Grenoble Institute of Neurosciences, Grenoble, France.
15 Centre Hospitalier Universitaire of Grenoble, Grenoble, France.
16 Department of Neurology, Landesklinikum Mistelbach-Gänserndorf, Mistelbach, Austria.
17 Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
18 Neurology Department, Clinica Universidad de Navarra, Pamplona, Spain.